An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections
暂无分享,去创建一个
Malak Kotb | Benjamin Schwartz | Glenys Thomson | Donald E. Low | G. Thomson | B. Schwartz | A. Norrby-Teglund | M. Kotb | D. Low | A. McGeer | K. Green | Karen Green | Allison McGeer | Anna Norrby-Teglund | Hesham El-Sherbini | M. Tevik Dorak | Ayesha Khurshid | Jeanie Peeples | Judy Wade | A. Khurshid | J. Wade | H. El-Sherbini | M. T. Dorak | J. Peeples | M. Tevik Dorak
[1] P. Linsley,et al. CD28 cross-linking augments TCR-mediated signals and costimulates superantigen responses. , 1995, Journal of immunology.
[2] O. Olerup,et al. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. , 1992, Tissue antigens.
[3] L. Burman,et al. Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. , 1991, The Journal of infectious diseases.
[4] R. Kaul,et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] R. Kaul,et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. , 1997, The American journal of medicine.
[6] K. Lundin,et al. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity. , 1996, Journal of immunology.
[7] Malak Kotb,et al. Genetic Relatedness and Superantigen Expression in Group A Streptococcus Serotype M1 Isolates from Patients with Severe and Nonsevere Invasive Diseases , 2000, Infection and Immunity.
[8] A. Norrby-Teglund,et al. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection , 2000, European journal of immunology.
[9] B. Schwartz,et al. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. , 1999, Infection and immunity.
[10] A. Norrby-Teglund,et al. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates , 1997, Infection and immunity.
[11] R. Kaul,et al. Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome—A Comparative Observational Study , 1999 .
[12] B. Schwartz,et al. The Reemergence of Severe Group A Streptococcal Disease: an Evolutionary Perspective , 1998 .
[13] J. Blackwell,et al. Genetics and genomics in infectious disease susceptibility. , 2001, Trends in molecular medicine.
[14] G. Thomson,et al. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. , 1999, Circulation.
[15] J. Ho. An epidemiologic and clinical study of nasopharyngeal carcinoma. , 1978, International journal of radiation oncology, biology, physics.
[16] M. Kotb,et al. Bacterial pyrogenic exotoxins as superantigens , 1995, Clinical microbiology reviews.
[17] P. Marrack,et al. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells , 1990, The Journal of experimental medicine.
[18] Martin Pr,et al. Streptococcal Serogroup: A Epidemic in Norway 1987–1988 , 1990 .
[19] B. Schwartz,et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. , 1993, JAMA.
[20] B. Schwartz,et al. Selective Depletion Of Vβ-Bearing T Cells In Patients With Severe Invasive Group A Streptococcal Infections And Streptococcal Toxic Shock Syndrome , 1995 .
[21] D E Low,et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. , 1996, The New England journal of medicine.
[22] A. Efstratiou,et al. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. , 1993, Journal of medical microbiology.
[23] A. Norrby-Teglund,et al. Evidence for superantigen involvement in severe group a streptococcal tissue infections. , 2001, The Journal of infectious diseases.
[24] S. Dye,et al. An evolutionary perspective of the knee. , 1987, The Journal of bone and joint surgery. American volume.